Author

J. Ishihara

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

J. K. Lee· 2 shared S. J. Priceman· 2 shared A. Ishihara· 1 shared A. Park· 1 shared A. Tsao· 1 shared A. Zhang· 1 shared B. Gittins· 1 shared C. Cullen· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. K. Lee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

E. Lee, C. Cullen, J. P. Murad, D. Gumber, A. Park, J. Yang, L. Stern, L. Adkins, G. Dhapola, B. Gittins, W.-C. Chang, C. Martinez, Y. Woo, M. Cristea, L. Rodriguez, , S. J. Priceman

This study develops TAG72-CAR T cells with antigen-dependent IL-12 signaling to enhance anti-tumor activity and systemic disease targeting in ovarian cancer.

bioRxiv · Jan 6, 2023 · PreprintCancer Biology

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell therapy

V. Bhatia, N. V. Kamat, T. E. Pariva, L.-T. Wu, A. Tsao, K. Sasaki, L. T. Wiest, A. Zhang, D. Rudoy, R. Gulati, R. A. Patel, M. P. Roudier, L. D. True, M. C. Haffner, P. S. Nelson, , J. K. Lee

This study develops STEAP1 CAR T cell therapy for advanced prostate cancer, showing potent antitumor activity and safety in preclinical models, but also identifies antigen loss as a resistance mechanism.

bioRxiv · May 16, 2022 · PreprintCancer Biology

Laminin heparin-binding peptides promiscuously bind growth factors and enhance diabetic wound healing

J. Ishihara, A. Ishihara, K. Fukunaga, P. S. Briquez, J. A. Hubbell

This study shows laminin heparin-binding peptides bind growth factors and enhance diabetic wound healing by acting as GF reservoirs and cell scaffolds.

bioRxiv · Feb 5, 2018Bioengineering